Bulletin
Investor Alert

Johnson & Johnson

NYS: JNJ

GO
/marketstate/country/us

After Hours

JNJ
/zigman2/quotes/201724570/composite

$

131.20

Change

-0.15 -0.11%

Volume

Volume 837,644

Nov 12, 2019, 7:47 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201724570/composite

Today's close

$ 131.98

$ 131.35

Change

-0.63 -0.48%

Day low

Day high

$131.02

$132.09

Open
Open: 132.00

52 week low

52 week high

$121.00

$148.99

Open

Market cap

$347.35B

Average volume

7.41M

P/E ratio

25.02

Rev. per Employee

$603,509

EPS

5.25

Dividend

0.95

Div yield

2.89%

Ex dividend date

11/25/19

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/jnj

MarketWatch News on JNJ

  1. Marine algae keys Chinese claim to Alzheimer’s breakthrough

    11:44 a.m. Nov. 9, 2019

    - Tanner Brown

  2. Teva and Other Opioid Defendant Stocks Jump on Strong Earnings

    10:40 a.m. Nov. 7, 2019

    - Josh Nathan-Kazis

  3. Teva earnings preview: Opioid suits are ‘key’

    12:37 p.m. Nov. 6, 2019

    - Jaimy Lee

  4. The Dow Is Going Nowhere, but GE and Mattel Stock Is Rising

    8:53 a.m. Oct. 30, 2019

    - Teresa Rivas

  5. Dow up 110 points on gains in shares of Microsoft, Goldman Sachs

    11:06 a.m. Oct. 28, 2019

    - Automated Insights

  6. 3M, Cisco share losses lead the way, but Dow flat

    3:25 p.m. Oct. 24, 2019

    - Automated Insights

  7. J&J Revises Earnings To Incorporate Proposed Opioid Deal

    11:18 a.m. Oct. 24, 2019

    - Josh Nathan-Kazis

  8. Johnson & Johnson restates earnings over opioid settlement

    6:45 p.m. Oct. 23, 2019

    - Wallace Witkowski

  9. Health Care Gains as a Warren Victory Looks Less Certain

    6:00 a.m. Oct. 23, 2019

    - Randall W. Forsyth

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/jnj

Other News on JNJ

  1. Geron: Hold Despite Slim Premium As Promising Trials Await Funding

    3:42 p.m. Today

    - Seeking Alpha

  2. Dividend Kings Analysis: Water Utilities Can Reduce Portfolio Volatility

    1:55 p.m. Today

    - Seeking Alpha

  3. Jeff Auxier Comments on Johnson & Johnson

    11:39 a.m. Nov. 11, 2019

    - GuruFocus.com

  4. Tracking Yacktman Asset Management Portfolio - Q3 2019 Update

    2:23 p.m. Nov. 10, 2019

    - Seeking Alpha

  5. 5 Safe And Cheap Dividend Stocks To Invest (November 2019)

    9:48 a.m. Nov. 9, 2019

    - Seeking Alpha

  6. Tracking Tweedy Browne Portfolio - Q3 2019 Update

    1:56 p.m. Nov. 8, 2019

    - Seeking Alpha

  7. Imbruvica combo OK'd in Canada for certain CLL patients

    9:04 a.m. Nov. 8, 2019

    - Seeking Alpha

  8. Nicholas Ward's Dividend Growth Portfolio: October Update

    7:42 p.m. Nov. 7, 2019

    - Seeking Alpha

  9. Monthly Portfolio Update: October 2019

    12:19 p.m. Nov. 7, 2019

    - Seeking Alpha

  10. Fidelity MSCI Health Care Index ETF Is Undervalued

    6:53 a.m. Nov. 7, 2019

    - Seeking Alpha

  11. Yacktman Focused Fund Comments on Johnson & Johnson

    11:57 a.m. Nov. 6, 2019

    - GuruFocus.com

  12. Loading more headlines...
/news/pressrelease/company/us/jnj

Press Releases on JNJ

  1. Orthobiologics Market 2019 by Excellent Revenue Growth by 2025 | MRE Research Report

    2:18 p.m. Today

    - Heraldkeepers

  2. Analgesics World Market Review 2015-2019 and Forecast to 2030 - ResearchAndMarkets.com

    2:13 p.m. Today

    - BusinessWire - BZX

  3. Global Vision Care Devices & Equipment Market Report 2020 - ResearchAndMarkets.com

    1:37 p.m. Today

    - BusinessWire - BZX

  4. Anticoagulants Market is Expected to Display a CAGR of 8.0% During 2018-2026 - TMR

    1:01 p.m. Today

    - The Express Wire

  5. Dental Drug Market 2019 In Deep Analysis, Expert Reviews and Healthcare Outlook 2024

    10:59 a.m. Today

    - Market Insight Reports

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.